Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +52.7% | -1909.1% | 1 / 3 | +55.7% | -3.78 pp | -0.04 pp | -0.2% | 0.04 | — | 260 | +55,7% | 4,8 | +52,7% | — | 6.00 | — |
| Pts | 8 | 0 | 4 | 12 | 0 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 5.500 (close price on 2026-10-19)EPS (TTM): −36,3
Financial charts
1.Revenue & growth
VND bn260Q2/26
1.Revenue & growth
VND bn260Q2/26
2.Profit & growth
VND bn4,75Q2/26
3.Profit mix (Penman)
VND bn0,19Q2/26
4.Margins & cost structure
%9.9%Q2/26
5.Returns & cash cycle
% · days-13.0%Q2/26
6.Earnings quality & cash
VND bn-63,7Q2/26
7.Asset structure
VND bn304Q2/26
8.Funding & debt health
VND bn · times304Q2/26
9.Revenue backlog
VND bn0,03Q2/26
10.Valuation
times · %-174,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.078Q2/26
Adjusted EPS growth, latest quarter
52.5%
Average adjusted EPS growth, 3 quarters
-1909%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26